Oxidative Stress and Apoptosis in Sepsis and the Adult Respiratory Distress Syndrome

  • T. Whitehead
  • H. Zhang
Conference paper


There has been considerable research into the role of reactive oxygen species (ROS) and more recently reactive nitrogen species in critical illness during the past decade. These highly reactive, short-lived compounds are generated continuously in normal cellular metabolism. Initially thought of as merely by-products to be detoxified as quickly as possible by the body’s numerous antioxidants, it is now recognized that they have important regulatory functions. Nevertheless, it is a widely accepted theory that during critical illness, particularly the acute respiratory distress syndrome (ARDS) and sepsis, and during conditions of ischemiareperfusion, the increased production of reactive species overwhelms the defense systems resulting in oxidant stress. This may contribute significantly to the morbidity and mortality of these conditions. Although a compelling theory, attempts to improve outcome in the critically sick with antioxidants have generally failed. In this article we shall briefly review the evidence for oxidant stress in sepsis and ARDS. We will then focus on one aspect of ROS in critical illness — their possible role in apoptosis, which is increasingly recognized as a key process in the critically ill patient.


Systemic Inflammatory Response Syndrome Critical Illness Multiple Organ Dysfunction Syndrome Adult Respiratory Distress Syndrome Neutrophil Apoptosis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Kietzmann D, Kahl R, Muller M et al (1993) Hydrogen peroxide in expired breath condensate of patients with acute respiratory failure and with ARDS. Intensive Care Med 19: 78–81PubMedCrossRefGoogle Scholar
  2. 2.
    Ogilvie AC, Groeneveld AB, Straub JP et al (1991) Plasma lipid peroxides and antioxidants in human septic shock. Intensive Care Med 17: 40–44PubMedCrossRefGoogle Scholar
  3. 3.
    Quinlan GJ, Lamb NJ, Evans TW et al (1996) Plasma fatty acid changes and increased lipid peroxidation in patients with adult respiratory distress syndrome. Crit Care Med 24: 241–246PubMedCrossRefGoogle Scholar
  4. 4.
    Quinlan GJ, Lamb NJ, Tilley R et al (1997) Plasma hypoxanthine levels in ARDS: implications for oxidative stress, morbidity and mortality. Am J Respir Crit Care Med 155: 479–484PubMedGoogle Scholar
  5. 5.
    Galley HF, Davies MJ, Webster NR (1996) Xanthine oxidase activity and free radical generation in patients with sepsis syndrome. Crit Care Med 24: 1649–1653PubMedCrossRefGoogle Scholar
  6. 6.
    Metnitz PGH, Bartens C, Fischer M et al (1999) Antioxidant status in patients with the respiratory distress syndrome. Intensive Care Med 25: 180–185PubMedCrossRefGoogle Scholar
  7. 7.
    Gutteridge JMC, Quinlan GJ, Mumby S et al (1994) Primary plasma anti-oxidants in adult respiratory distress syndrome patients: changes in iron oxidising, iron-binding and free radical-scavenging proteins. J Lab Clin Med 124: 263–267PubMedGoogle Scholar
  8. 8.
    Goode HF, Cowley HC, Walker BE et al (1995) Decreased antioxidant status and increased lipid peroxidation in patients with septic shock and secondary organ dysfunction. Crit Care Med 23: 646–651PubMedCrossRefGoogle Scholar
  9. 9.
    Kong CW, Tsai K, Chin JH et al (2000) Magnolol attenuates peroxidative damage and improves survival of rats with sepsis. Shock 13: 24–28PubMedCrossRefGoogle Scholar
  10. 10.
    Bakker J, Zhang H, Depierreux M et al (1994) Effects of n-acetylcysteine in endotoxic shock. J Crit Care 9: 236–243PubMedCrossRefGoogle Scholar
  11. 11.
    Gonzalez PK, Zhuang J, Doctrow SR et al (1996) Role of oxidant stress in the adult respiratory distress syndrome: evaluation of a novel antioxidant strategy in a porcine model of endotoxin-induced lung injury. Shock 6[Suppl 1]: S23–26PubMedGoogle Scholar
  12. 12.
    Davreux CJ, Soric I, Nathens AB et al (1997) n-acetyl cysteine attenuates lung injury in the rat. Shock 8: 432–438PubMedCrossRefGoogle Scholar
  13. 13.
    Robbins CG, Horowitz S, Merritt TA et al (1997) Recombinant human Superoxide dismutase reduces lung injury caused by inhaled nitric oxide and hyperoxia. Am J Physiol 272: L903–L907PubMedGoogle Scholar
  14. 14.
    Haslett C (1997) Granulocyte apoptosis and inflammatory disease. Br Med Bull 53: 669–683PubMedGoogle Scholar
  15. 15.
    Clutton S (1997) The importance of oxidative stress in apoptosis. Br Med Bull 53: 662–668PubMedGoogle Scholar
  16. 16.
    Mahidhara R, Billiar TR (2000) Apoptosis in sepsis. Crit Care Med 28[Suppl 4]: 104–113Google Scholar
  17. 17.
    Fanning NF, Kell MR, Shorten GD et al (1999) Circulating granulocyte macrophage colonystimulating factor in plasma of patients with the systemic inflammatory response syndrome delays neutrophil apoptosis through inhibition of spontaneous reactive oxygen species generation. Shock 11: 167–174PubMedCrossRefGoogle Scholar
  18. 18.
    Rollet-Labelle E, Grange MJ, Elbim C et al (1998) Hydroxyl radical as a potential intracellular mediator of polymorphonuclear neutrophil apoptosis. Free Radic Biol Med 24: 563–572PubMedCrossRefGoogle Scholar
  19. 19.
    Aoshiba K, Yasui S, Hayashi M et al (1999) Role of mitogen-activated protein kinase in spontaneous apoptosis of human neutrophils. J Immunol 162: 1692–1700PubMedGoogle Scholar
  20. 20.
    Fadeel B, Ahlin A, Henter J et al (1998) Involvement of caspases in neutrophil apoptosis: regulation by reactive oxygen species. Blood 92: 4808–4818PubMedGoogle Scholar
  21. 21.
    Matute-Bello G, Liles WC, Radella F et al (1997) Neutrophil apoptosis in the acute respiratory distress syndrome. Am J Respir Crit Care Med 156: 1969–1977PubMedGoogle Scholar
  22. 22.
    Matute-Bello G, Liles WC, Radella F et al (2000) Modulation of neutrophil apoptosis by granulocyte colony-stimulating factor and granulocyte/macrophage stimulating factor during the course of the acute respiratory distress syndrome. Crit Care Med 28: 1–7PubMedCrossRefGoogle Scholar
  23. 23.
    Hotchkiss RS, Swanson PE, Freeman BD et al (1999) Apoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction. Crit Care Med 27: 1230–1251PubMedCrossRefGoogle Scholar
  24. 24.
    Hildeman DA, Mitchell T, Teague TK et al (1999) Reactive oxygen species regulate activation-induced T cell apoptosis. Immunity 10: 735–744PubMedCrossRefGoogle Scholar
  25. 25.
    Romero-Alvira D, Roche E (1998) The keys of oxidative stress in acquired immune deficiency syndrome apoptosis. Med Hypotheses 51: 169–173PubMedCrossRefGoogle Scholar
  26. 26.
    Freeman BD, Reaume AG, Swanson PE et al (2000) Role of CuZn Superoxide dismutase in regulating lymphocyte apoptosis during sepsis. Crit Care Med 28: 1701–1708PubMedCrossRefGoogle Scholar
  27. 27.
    Hotchkiss RS, Swanson PE, Cobb JP et al (1999) Overexpression of Bcl-2 in transgenic mice decreases apoptosis and improves survival in sepsis. J Immunol 162: 4148–4156PubMedGoogle Scholar
  28. 28.
    Hockenbury DM, Oltavai ZN, Yin XM et al (1993) Bcl-2 functions as an antioxidant pathway to prevent apoptosis. Cell 75: 241–251CrossRefGoogle Scholar
  29. 29.
    Jacobson MD (1996) Reactive oxygen species and programmed cell death. Trends Biochem Sci 21: 83–86PubMedGoogle Scholar
  30. 30.
    Papathanassoglou ED, Moynihan JA, Ackerman MH (2000) Does programmed cell death (apoptosis) play a role in the development of multiple organ dysfunction in critically ill patients? A review and a theoretical framework. Crit Care Med 28: 537–549PubMedCrossRefGoogle Scholar
  31. 31.
    Hotchkiss RS, Swanson PE, Cobb JP et al (1997) Apoptosis in lymphoid and parenchymal cells during sepsis: findings in normal and T-and B-cell-deficient mice. Crit Care Med 25: 1298–1307PubMedCrossRefGoogle Scholar
  32. 32.
    Bohlinger I, Leist M, Gantner F et al (1996) DNA fragmentation in mouse organs during endotoxic shock. Am J Pathol 49: 1381–1393Google Scholar
  33. 33.
    Haimovitz-Friedman A, Cordon-Cardo C, Bayoumy S et al (1997) Lipopolysaccharide induces disseminated endothelial apoptosis requiring ceramide generation. J Exp Med 186: 1831–1841PubMedCrossRefGoogle Scholar
  34. 34.
    Abello PA, Fidler SA, Buchman TG (1994) Thiol reducing agents modulate induced apoptosis in porcine endothelial cells. Shock 2: 79–83PubMedCrossRefGoogle Scholar
  35. 35.
    Drab-Weiss EA, Hansra IK, Blazek ER et al (1998) Aminothiols protect endothelial cell proliferation against inhibition by lipopolysaccharide. Shock 10: 423–429PubMedCrossRefGoogle Scholar
  36. 36.
    Dimmeler S, Zeiher AM (1996) Nitric oxide — an endothelial cell survival factor. Cell Death Differ 6: 964–968CrossRefGoogle Scholar
  37. 37.
    Sundaresan M, Yu S-Z, Ferrans V et al (1995) Requirement for generation of H2O2 for platelet-derived growth factor signal transduction. Science 270: 296–299PubMedCrossRefGoogle Scholar
  38. 38.
    Bae YS, Kang SW, Seo MS et al (1997) Epidermal growth factor (EGF) — induced generation of hydrogen peroxide. J Biol Chem 272: 217–221PubMedCrossRefGoogle Scholar
  39. 39.
    Compton CN, Franko AP, Murray MT et al (1998) Signaling of apoptotic lung injury by lipid hydroperoxides. J Trauma 44: 783–788PubMedCrossRefGoogle Scholar
  40. 40.
    Esterbauer H, Schaur RJ, Zollner H et al (1999) Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med 11: 81–128CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Italia, Milano 2001

Authors and Affiliations

  • T. Whitehead
  • H. Zhang

There are no affiliations available

Personalised recommendations